BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23725526)

  • 1. Improvement of fasting plasma glucose level after ingesting moderate amount of dietary fiber in Japanese men with mild hyperglycemia and visceral fat obesity.
    Kobayakawa A; Suzuki T; Ikami T; Saito M; Yabe D; Seino Y
    J Diet Suppl; 2013 Jun; 10(2):129-41. PubMed ID: 23725526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial.
    Liu Y; Cotillard A; Vatier C; Bastard JP; Fellahi S; Stévant M; Allatif O; Langlois C; Bieuvelet S; Brochot A; Guilbot A; Clément K; Rizkalla SW
    PLoS One; 2015; 10(9):e0138646. PubMed ID: 26406981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study.
    Shirai K; Fujita T; Tanaka M; Fujii Y; Shimomasuda M; Sakai S; Samukawa Y
    Adv Ther; 2019 Jan; 36(1):86-100. PubMed ID: 30535651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in visceral adiposity and serum cholesterol with a novel viscous polysaccharide in Japanese adults with abdominal obesity.
    Reimer RA; Yamaguchi H; Eller LK; Lyon MR; Gahler RJ; Kacinik V; Juneja P; Wood S
    Obesity (Silver Spring); 2013 Sep; 21(9):E379-87. PubMed ID: 23512917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial.
    Smith SR; Stenlof KS; Greenway FL; McHutchison J; Schwartz SM; Dev VB; Berk ES; Kapikian R
    Obesity (Silver Spring); 2011 Sep; 19(9):1796-803. PubMed ID: 21720429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in overweight men: a double-blind, randomized, placebo-controlled study.
    Li S; Guerin-Deremaux L; Pochat M; Wils D; Reifer C; Miller LE
    Appl Physiol Nutr Metab; 2010 Dec; 35(6):773-82. PubMed ID: 21164548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent anti-obesity effect of enteric-coated lactoferrin: decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets.
    Ono T; Murakoshi M; Suzuki N; Iida N; Ohdera M; Iigo M; Yoshida T; Sugiyama K; Nishino H
    Br J Nutr; 2010 Dec; 104(11):1688-95. PubMed ID: 20691130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin treatment to reduce central adiposity after prenatal growth restraint: a placebo-controlled pilot study in prepubertal children.
    Díaz M; Bassols J; López-Bermejo A; de Zegher F; Ibáñez L
    Pediatr Diabetes; 2015 Nov; 16(7):538-45. PubMed ID: 25332100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Whole Grain Wheat Bread on Visceral Fat Obesity in Japanese Subjects: A Randomized Double-Blind Study.
    Kikuchi Y; Nozaki S; Makita M; Yokozuka S; Fukudome SI; Yanagisawa T; Aoe S
    Plant Foods Hum Nutr; 2018 Sep; 73(3):161-165. PubMed ID: 29671172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of high β-glucan barley on visceral fat obesity in Japanese individuals: A randomized, double-blind study.
    Aoe S; Ichinose Y; Kohyama N; Komae K; Takahashi A; Abe D; Yoshioka T; Yanagisawa T
    Nutrition; 2017 Oct; 42():1-6. PubMed ID: 28870472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meal replacement regimen improves blood glucose levels in prediabetic healthy individuals with impaired fasting glucose.
    König D; Kookhan S; Schaffner D; Deibert P; Berg A
    Nutrition; 2014; 30(11-12):1306-9. PubMed ID: 25194963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
    Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
    Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of sibutramine on blood glucose and lipids, body fat mass and insulin resistance in obese patients: a multi-center clinical trial].
    Tong NW; Ran XW; Li QF; Tang BD; Li R; Yang FY; Liu YP; Li XJ
    Zhonghua Nei Ke Za Zhi; 2005 Sep; 44(9):659-63. PubMed ID: 16202254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases.
    Faber DR; van der Graaf Y; Westerink J; Visseren FL
    Atherosclerosis; 2010 Sep; 212(1):274-80. PubMed ID: 20494358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance in patients with stroke is related to visceral fat obesity and adipocytokines.
    Hishinuma A; Majima M; Kurabayashi H
    J Stroke Cerebrovasc Dis; 2008; 17(4):175-80. PubMed ID: 18589336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactic-fermented egg white improves visceral fat obesity in Japanese subjects-double-blind, placebo-controlled study.
    Matsuoka R; Kamachi K; Usuda M; Wang W; Masuda Y; Kunou M; Tanaka A; Utsunomiya K
    Lipids Health Dis; 2017 Dec; 16(1):237. PubMed ID: 29216922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control.
    Ahn CW; Kim CS; Nam JH; Kim HJ; Nam JS; Park JS; Kang ES; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):444-9. PubMed ID: 16584518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial.
    Mielgo-Ayuso J; Barrenechea L; Alcorta P; Larrarte E; Margareto J; Labayen I
    Br J Nutr; 2014 Apr; 111(7):1263-71. PubMed ID: 24299662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity.
    Borel AL; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
    Metabolism; 2012 Feb; 61(2):262-72. PubMed ID: 21864868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of bofu-tsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance.
    Hioki C; Yoshimoto K; Yoshida T
    Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):614-9. PubMed ID: 15479169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.